Patients on long-term non-steroidal anti-inflammatory drugs (NSAID) were seen to have a reduced risk of developing Alzheimer's disease, but the mechanisms underlying this observation remain unclear.
Table 1. Suggested strategies for analgesic/anti-inflammatory treatment and cardiovascular prevention among patients with inflammatory disease and different levels of risk of vascular events. Risk of ...